Live feed
Filing
SC 13G/A
SC 13G/A0000903423-19-000020·Eidos Therapeutics, Inc.
Schedule 13G ownership disclosure
EIDOS THERAPEUTICS INC
Security class unavailable · CUSIP: 28249H104
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,986,201
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-19-000020
- Form type
- SC 13G/A
- Filer
- Eidos Therapeutics, Inc.
- CIK
- CIK 1731831
- Filed
- Jan 10, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership